Abstract:Abstract Determining a molecule’s mechanism of action is paramount during chemical probe development and drug discovery. The cellular thermal shift assay (CETSA) is a valuable tool to confirm target engagement in cells for a small molecule that demonstrates a pharmacological effect. CETSA directly detects biophysical interactions between ligands and protein targets, which can alter a protein’s unfolding and aggregation properties in response to thermal challenge. In traditional CETSA experiments, each temperature requires an individual sample, which restricts throughput and requires substantial optimization. To capture the full aggregation profile of a protein from a single sample, we developed a prototype real-time CETSA (RT-CETSA) platform by coupling a real-time PCR instrument with a CCD camera to detect luminescence. A thermally stable Nanoluciferase variant (ThermLuc) was bioengineered that withstood unfolding at temperatures greater than 90 degrees Celsius and was compatible with monitoring target engagement events when fused to diverse targets. Utilizing well-characterized inhibitors of lactate dehydrogenase alpha, RT-CETSA showed significant correlation with enzymatic, biophysical, and other cell-based assays. A data analysis pipeline was developed to enhance the sensitivity of RT-CETSA to detect on-target binding. The RT-CETSA technology advances capabilities of the CETSA method and facilitates the identification of ligand-target engagement in cells, a critical step in assessing the mechanism of action of a small molecule. Significance Validating target engagement is a critical step when characterizing a small molecule modulator. The cellular thermal shift assay (CETSA) is a common approach to examine target engagement, as alterations in the thermal stability of a protein can be conferred by ligand binding. An advantage of CETSA is that it does not require modification of the protein target or small molecule. Major limitations are the throughput and ease-of-use, as the traditional detection method uses western blots, which limits the number of samples that can be processed. Higher-throughput CETSA methods have been developed but are performed at a single temperature and require target-specific optimization. We developed a high-throughput real-time CETSA to circumvent these challenges, providing a rapid and cost-effective strategy to assess on-target activity of a small molecule in living cells.

Identification of Ligand Binding by Protein Stabilization: Comparison of ATLAS with Biophysical and Enzymatic Methods

ATLAS—A High-Throughput Affinity-Based Screening Technology for Soluble Proteins: Technology Application Using P38 MAP Kinase

Biophysical screening for the discovery of small-molecule ligands

A New Assay Based on Fluorescence Resonance Energy Transfer to Determine the Binding Affinity of Bcl-xLInhibitors

Investigating Protein Binding with the Isothermal Ligand‐induced Resolubilization Assay

A computational method for detection of ligand-binding proteins from dose range thermal proteome profiles

MALDI-TOF-Based Affinity Selection Mass Spectrometry for Automated Screening of Protein-Ligand Interactions at High Throughput

Fast Screening of Ligand-Protein Interactions Based on Ligand-Induced Protein Stabilization of Gold Nanoparticles.

Analysis of Protein Stability and Ligand Interactions by Thermal Shift Assay

Identifying ligand binding sites and poses using GPU-accelerated Hamiltonian replica exchange molecular dynamics

Integrated Protein Solubility Shift Assays for Comprehensive Drug Target Identification on a Proteome-Wide Scale

Inhibitor Library Screening of SH2 Domains Through Denaturation-Based Assays

Determination of Protein-Ligand Binding Affinities by Thermal Shift Assay

A real-time cellular thermal shift assay (RT-CETSA) to monitor target engagement

Identifying The Proteins To Which Small-Molecule Probes And Drugs Bind In Cells

Immobilized Angiotensin II Type I Receptor: A Powerful Method of High Throughput Screening for Antihypertensive Compound Identification Through Binding Interaction Analysis.

Identification of selective ligands targeting two GPCRs by receptor-affinity chromatography coupled with high-throughput sequencing techniques

Computational analysis of ligand dose range thermal proteome profiles

A fragment based competitive 19F LB‐NMR platform for hotspot directed ligand profiling

A peptide-centric local stability assay enables proteome-scale identification of the protein targets and binding regions of diverse ligands

Large-scale characterization of drug mechanism of action using proteome-wide thermal shift assays